Pharmaceutical Business Review
Anonymous User | Login

US States Join Medicaid’s Lawsuits Against Wyeth

Published: 18-May-2009

The US Justice Department has joined forces with 16 states in a legal fight against Wyeth, alleging that the drug maker has failed to reimburse hundreds of millions of dollars to Medicaid – a joint federal-state healthcare program for the poor.

The states which are up against Wyeth are California, Delaware, the District of Columbia, Florida, Illinois, Indiana, Louisiana, Massachusetts, Michigan, New Hampshire, New York, Nevada, Tennessee, Texas, Virginia, and Wisconsin, according to forbes.com.

The lawsuits were originally filed in Massachusetts alleging that Wyeth had not given the same discounts to Medicaid program that it gave to private hospitals.

The lawsuits accuse Wyeth of giving steep discounts to private hospitals on drugs such as Protonix Oral and Protonix IV that reduce stomach acid, with a motive of winning the retail business of the same patients once they were discharged from the hospital.

Michael Loucks, US Attorney for the District of Massachusetts, said: “The best price reporting requirement is designed to assure that the nation's healthcare programs for the poor - the Medicaid programs - are treated equally with drug companies' best commercial customers.”

Meanwhile, Wyeth’s spokesman Douglas Petkus said that Wyeth would fight the charges in court. The company believes that its pricing calculations were correct and intends to defend itself vigorously in these actions, he said.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Kuecept

Concept Formulation Design ...

Pharma IQ

Workshops, Conferences and Training Courses for Pharmaceutical Professionals ...

Capsugel

Providing Innovative Doasge Forms and Solutions to Health Care Customers ...

MHRA

The Medicines and Healthcare Products Regulatory Agency ...

Nycomed

Contract Services ...

Medilingua Translations

The Medical Translation Specialists ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

Roche Holding Ltd

Roche Holding Ltd (Roche) is one of the major research based healthcare group in the wo ...

Baxter International Inc.

Baxter International Inc. (Baxter) is a global health care company specializing in medi ...

Amgen Inc.

Amgen Inc. (Amgen) is a biotechnology company that is focused on the discovery, develo ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Fresenius SE

Fresenius SE (Fresenius) is a global health care group, which provides dialysis treatme ...

Suppliers Product News

Kuecept and The School of Pharmacy Agree Key Drug Delivery Licensing

Kuecept Ltd and The School of Pharmacy, University of London agree key drug delivery licensing deals to facilitate the development of low solubility, poorly bioavailable compounds.

Synectix Pharmaceutical Solutions Now Called Kuecept

Synectix Pharmaceutical Solutions Ltd, the speciality drug development company, announced today that effective immediately, the company has changed its name to Kuecept Ltd.

Quality Control in Medical Translation

Various methods are available to ensure the quality of medical translations – but some are more effective than others.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address